Summary of SRES 285: Glioblastoma Awareness Day Resolution
Bill Number: SRES 285
Title: A resolution designating July 16, 2025, as "Glioblastoma Awareness Day"
Status: Introduced in Senate
Introduced On: June 17, 2025
Classification: Resolution
Purpose and Intent
The primary purpose of SRES 285 is to designate July 16, 2025, as "Glioblastoma Awareness Day." This resolution aims to raise public awareness about glioblastoma, a highly aggressive form of brain cancer, and to honor those affected by the disease. By establishing a specific day for awareness, the resolution seeks to foster understanding and support for individuals battling glioblastoma and their families.
Key Provisions
The resolution includes several important provisions:
- Designation of Awareness Day: Officially recognizes July 16, 2025, as Glioblastoma Awareness Day.
- Public Awareness: Encourages efforts to increase public knowledge about glioblastoma and its impact.
- Honoring Affected Individuals: Pays tribute to those who have lost their lives to glioblastoma and those currently living with the disease.
- Support for Treatment Development: Advocates for improved treatment options that enhance the prognosis and quality of life for patients diagnosed with glioblastoma.
- Importance of Biomarker Testing: Recognizes the critical role of molecular biomarker testing in diagnosing and treating glioblastoma.
- Support for Patients and Caregivers: Expresses solidarity with individuals battling brain tumors and acknowledges the support systems of families and caregivers.
- Collaborative Research Approach: Urges a cooperative effort among governmental, private, and nonprofit organizations to advance glioblastoma research.
- Investment in Research: Encourages ongoing financial support for glioblastoma research and treatment initiatives, including those facilitated by the Glioblastoma Therapeutics Network.
Who Would Be Affected
The resolution primarily impacts the following groups:
- Patients: Individuals diagnosed with glioblastoma and their families.
- Healthcare Providers: Medical professionals involved in the diagnosis and treatment of glioblastoma.
- Researchers: Scientists and organizations focused on brain tumor research and treatment development.
- Advocacy Groups: Nonprofit organizations dedicated to raising awareness and funding for glioblastoma research.
Legislative Actions
- June 17, 2025: The resolution was submitted in the Senate, considered, and agreed to without amendment by unanimous consent.
- Related Bills: HRES 394 serves as a companion resolution in the House of Representatives.
Sponsors
The resolution is sponsored by a bipartisan group of senators, including:
- Primary Sponsor: Lindsey Graham
- Cosponsors: Ruben Gallego, Mark Kelly, Raphael Warnock, Tim Scott, Elizabeth A. Warren, Chris Van Hollen, Christopher A. Coons, John Barrasso, Edward J. Markey
Conclusion
SRES 285 serves as a significant step towards increasing awareness and support for glioblastoma, a challenging disease that affects many individuals and families. By designating a specific day for awareness, the resolution aims to promote education, research collaboration, and improved treatment options for those impacted by glioblastoma.
